✦ LIBER ✦

Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma

✍ Scribed by Toshihito Seki; Toru Tamai; Taiichi Nakagawa; Masato Imamura; Akira Nishimura; Noriyo Yamashiki; Kozo Ikeda; Kyoichi Inoue

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 115 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000915)89:6<1245::aid-cncr8>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percutaneous microwave coagulation thera

Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma : Comparison with percutaneous ethanol injection therapy

✍ Toshihito Seki; Masayuki Wakabayashi; Taiichi Nakagawa; Masato Imamura; Toru Tam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. The authors compared the efficacy of percutaneous microwave coagulation therapy (PMCT) and percutaneous ethanol injection therapy (PEIT) in the treatment of patients with cirrhosis and a solitary nodular hepatocellular carcinoma (HCC) Յ 2 cm in greatest dimension. ## METHODS. Of

Combination therapy with transcatheter a

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma : A randomized control study

✍ Masahiko Koda; Yoshikazu Murawaki; Akeri Mitsuda; Kenji Oyama; Kinya Okamoto; Yo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Percutaneous radiofrequency ablation the

Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma

✍ Takahiro Yamasaki; Fumie Kurokawa; Hitoshi Shirahashi; Noriyoshi Kusano; Kouji H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

## BACKGROUND. Radiofrequency ablation (RFA) for patients with hepatocellular carcinoma (HCC) has been reported previously. This technique is superior to percutaneous microwave coagulation therapy (PMCT) for the enlargement of the necrotic area. Therefore, a few treatment sessions of RFA for patie

Transcatheter arterial chemoembolization

Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma : Evaluation of three kinds of regimens and analysis of prognostic factors

✍ Kazuto Ueno; Nobuaki Miyazono; Hiroki Inoue; Hirotoshi Nishida; Ichiro Kanetsuki 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

The current study was conducted to evaluate retrospectively the effects of three kinds of regimens used in transcatheter arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC) and patients' prognosis, and to analyze their prognostic factors. ## METHODS. The

The long term efficacy of combined trans

The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis

✍ Katsuaki Tanaka; Saburo Nakamura; Kazushi Numata; Masaaki Kondo; Katsumi Morita; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: The long term efficacy of combination therapy with transcatheter arterial embolization (tae) followed by percutaneous ethanol injection (pei) was studied in patients with large primary hepatocellular carcinoma (hcc) tumors and cirrhosis. ## Methods: The series included 83 patients

Prognostic factors for survival in patie

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy

✍ Maurizio Pompili; Gian Ludovico Rapaccini; Marcello Covino; Giulia Pignataro; Eu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec